Between 2021 and 2023, commercial insurance carriers in Rhode Island spent over $120 million on GLP-1 medications alone
Use the account's subscription management tools and cancel at least two days before renewal
Peer review Peer review information Nature Immunology thanks Philipp Henneke and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Why GLP-1 Medications Stood Out in 2024 GLP-1 (Glucagon-Like Peptide-1) receptor agonists, such as Ozempic and Mounjaro , have long been some of the most effective tools for sustainable weight loss
If you're in the Plano, Frisco, Allen, McKinney, or Dallas area and struggling with digestive issues related to GLP-1 medications, I'm here to help